Seattle, Aug. 20, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global Tylosin market was valued at US$ 379.0 million in 2017 and is projected to exhibit a CAGR of 1.2% over the forecast period (2018–2026).

Key Trends and Analysis of the Tylosin Market: 

Tylosin is available under brand names such as Tylan (Tylosin Phosphate) by Elanco, Tylovet (Tylosin Phosphate) by Huvepharma, Tylan Soluble (Tylosin Tartrate) by Elanco, and others. The demand for antibiotics for preventing infection in livestock is on the rise, owing to increasing need for healthy livestock for human consumption. Antibiotics such as Tylosin prevents against mycoplasmosis in several animals such as chickens, turkeys, pigs, and calves.  Tylosin is orally administered in required dosage in order to prevent said infections and to grow healthy livestock.

Tylosin is available in various forms and can be used in combination with several additives. Manufacturers such as Elanco Animal Health, Zoetis, Tairui Pharmaceuticals, AdvaCare Pharma, and others offer Tylosin in various forms such as active pharmaceutical ingredient and solid dosage forms. Tylosin is generally available in veterinary soluble powder and granule forms. The U.S. Food & Drug Administration (FDA) approved new combination uses of Zoetis feed additives, ACTOGAIN 45 (ractopamine hydrochloride) and Engain (ractopamine hydrochloride) in 2015. ACTOGAIN 45 can be used with Rumensin (monensin USP) plus Tylovet 100 (tylosin phosphate).

Furthermore, key players in the Tylosin market are focused on new acquisitions and mergers. For instance, in January 2018, Huvepharma acquired AgriLabs to expand its presence in the U.S. Moreover, in 2015, Elanco released an eight-point antibiotic stewardship plan to outline global actions for the company to ensure long-term access to antibiotics for people and animals.

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market...arket-2061

Key Market Takeaways:

  • The global Tylosin market is expected to exhibit CAGR of 1.2% during the forecast period (2018–2026). This growth is attributed to increasing demand for antibiotics in livestock and various available products and dosage forms of tylosin such as tylosin tartrate and phosphate
  • North America and Europe are expected to witness significant growth due to presence of key manufacturers such as Zoetis and Elanco Animal Health
  • Key players operating in the global tylosin market include, Zoetis, Tairui Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare Pharma, and Elanco Animal Health

Buy this Market Intelligence Report Now

or

Request Sample Copy of this Report before Buying

Mr. Shah Coherent Market Insights 1001 4th Ave. #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com